$9.45
4.19% day before yesterday
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US03475V1017
Symbol
ANGO

AngioDynamics, Inc. Stock price

$9.45
+0.32 3.50% 1M
-0.63 6.25% 6M
+0.29 3.17% YTD
+1.94 25.83% 1Y
-13.35 58.55% 3Y
+0.39 4.25% 5Y
-4.86 33.96% 10Y
-12.51 56.97% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.38 4.19%

Key metrics

Basic
Market capitalization
$384.0m
Enterprise Value
$334.3m
Net debt
positive
Cash
$55.9m
Shares outstanding
41.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.3 | 1.2
EV/Sales
1.1 | 1.1
EV/FCF
negative
P/B
2.1
Financial Health
Equity Ratio
65.3%
Return on Equity
-18.6%
ROCE
-11.9%
ROIC
-13.2%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$292.5m | $313.3m
EBITDA
$-14.0m | $5.5m
EBIT
$-24.3m | $-30.2m
Net Income
$-34.0m | $-9.5m
Free Cash Flow
$-14.6m
Growth (TTM | estimate)
Revenue
-3.8% | 7.1%
EBITDA
33.9% | 138.9%
EBIT
29.0% | -24.1%
Net Income
81.6% | 72.1%
Free Cash Flow
57.0%
Margin (TTM | estimate)
Gross
53.9%
EBITDA
-4.8% | 1.7%
EBIT
-8.3%
Net
-11.6% | -3.0%
Free Cash Flow
-5.0%
More
EPS
$-0.8
FCF per Share
$-0.4
Short interest
11.0%
Employees
748
Rev per Employee
$390.0k
Show more

Is AngioDynamics, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

AngioDynamics, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a AngioDynamics, Inc. forecast:

Buy
90%
Hold
10%

Financial data from AngioDynamics, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
May '25
+/-
%
293 293
4% 4%
100%
- Direct Costs 135 135
10% 10%
46%
158 158
2% 2%
54%
- Selling and Administrative Expenses 145 145
1% 1%
50%
- Research and Development Expense 26 26
17% 17%
9%
-14 -14
34% 34%
-5%
- Depreciation and Amortization 10 10
21% 21%
4%
EBIT (Operating Income) EBIT -24 -24
29% 29%
-8%
Net Profit -34 -34
82% 82%
-12%

In millions USD.

Don't miss a Thing! We will send you all news about AngioDynamics, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AngioDynamics, Inc. Stock News

Positive
Seeking Alpha
7 days ago
AngioDynamics has completed a strategic transformation, divesting non-core assets and focusing on high-growth MedTech platforms, driving accelerating revenue and margin improvement. Recent results confirm an inflection point: MedTech sales grew 19.5% in FY25, adjusted EBITDA turned positive, and the company now boasts a strong net cash balance sheet. Favorable sector trends, regulatory wins, an...
Neutral
Business Wire
17 days ago
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options, and improving quality of life for patients, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President a...
Neutral
Business Wire
27 days ago
LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced enrollment of the first patient in the Randomized Study of the Auryon Atherectomy System Used in Combination with Standard Balloon Angioplas...
More AngioDynamics, Inc. News

Company Profile

AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.

Head office United States
CEO James Clemmer
Employees 748
Founded 1988
Website www.angiodynamics.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today